CHELSEA HINDMAN: Open Payments
NPI 1811492564 · RED BANK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 14 payments from 10 companies in 2025. Trend: 2023 $1,212 · 2024 $577 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $50 |
| ABBVIE INC. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: SHINGRIX, UBRELVY, FASENRA, Auvelity, Dexcom G6 Transmitter, Tirosint, XYOSTED, YUPELRI.
Industry payments across NJ — which companies pay providers there.
